We performed a histological and immunohistochemical analysis of myocardia from 3 patients who underwent radiosurgery and died for various reasons 3 months to 9 months after radiotherapy. In Case 1 (death 3 months after radiotherapy) we observed a sharp transition between relatively intact and irradiated regions. In the myolytic foci, only scattered cardiomyocytes were left and the area was infiltrated by immune cells. Using immunohistochemistry we detected numerous inflammatory cells including CD68+/CD11c+ macrophages, CD4+ and CD8+ T-lymphocytes and some scattered CD20+ B-lymphocytes. Mast cells were diminished in contrast to viable myocardium. In Case 2 and Case 3 (death 6 and 9 months after radiotherapy, respectively) we found mostly fibrosis, infiltration by adipose tissue and foci of calcification. Inflammatory infiltrates were less pronounced. Our observations are in accordance with animal experimental studies and confirm a progress from myolysis to fibrosis. In addition, we demonstrate a role of pro-inflammatory macrophages in the earlier stages of myocardial remodeling after stereotactic radioablation for ventricular tachycardia.

Department of Cardiology Institute for Clinical and Experimental Medicine Vídeňská 1958 140 21 Prague Czech Republic

Department of Oncology University Hospital Ostrava 17 listopadu 1790 708 52 Ostrava Czech Republic

Department of Pathology Institute for Clinical and Experimental Medicine Vídeňská 1958 140 21 Prague Czech Republic

Faculty of Medicine Masaryk University Brno Kamenice 753 5 625 00 Brno; Agel Hospital Třinec Podlesí a s Konská 453 739 61 Třinec Czech Republic

Institute of Clinical and Molecular Pathology and Medical Genetics University Hospital Ostrava 17 listopadu 1790 708 52 Ostrava Czech Republic

Institute of Histology and Embryology 1st Faculty of Medicine Charles University Albertov 4 120 00 Prague Czech Republic

See more in PubMed

Wei C, Qian PRC, Boeck M, Bredfeldt JS, Blankstein R, Tedrow UB, et al. Cardiac stereotactic body radiation therapy for ventricular tachycardia: Current experience and technical gaps. J Cardiovasc Electr. 2021;32:2901–2914. PubMed

Zhang DM, Szymanski J, Bergom C, Cuculich PS, Robinson CG, Schwarz JK, et al. Leveraging Radiobiology for Arrhythmia Management: A New Treatment Paradigm? Clin Oncol-Uk. 2021;33:723–734. PubMed

Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015;12:1997–2007. PubMed PMC

Jumeau R, Ozsahin M, Schwitter J, Elicin O, Reichlin T, Roten L, et al. Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions. Front Cardiovasc Med. 2020;7:1–11. PubMed PMC

van der Ree MH, Blanck O, Limpens J, Lee CH, Balgobind BV, Dieleman EMT, et al. Cardiac radioablation-A systematic review. Heart Rhythm. 2020;17:1381–1392. PubMed

Lloyd MS, Wight J, Schneider F, Hoskins M, Attia T, Escott C, et al. Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients. Heart Rhythm. 2020;17:415–422. PubMed

Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, et al. Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia. New Engl J Med. 2017;377:2325–2336. PubMed PMC

Kiani S, Kutob L, Schneider F, Higgins KA, Lloyd MS. Histopathologic and Ultrastructural Findings in Human Myocardium After Stereotactic Body Radiation Therapy for Recalcitrant Ventricular Tachycardia. Circ-Arrhythmia Elec. 2020;13:1303–1310. PubMed

Kautzner J, Jedlickova K, Sramko M, Peichl P, Cvek J, Ing LK, et al. Radiation-Induced Changes in Ventricular Myocardium After Stereotactic Body Radiotherapy for Recurrent Ventricular Tachycardia. JACC Clin Electrophysiol. 2021;7:1487–1492. PubMed

Lehmann HI, Graeff C, Simoniello P, Constantinescu A, Takami M, Lugenbiel P, et al. Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams. Sci Rep-Uk. 2016;6:1–13. PubMed PMC

Rapp F, Simoniello P, Wiedemann J, Bahrami K, Grunebaum V, Ktitareva S, et al. Biological Cardiac Tissue Effects of High-Energy Heavy Ions - Investigation for Myocardial Ablation. Sci Rep-Uk. 2019;9:1–13. PubMed PMC

Sharma A, Wong D, Weidlich G, Fogarty T, Jack A, Sumanaweera T, et al. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm. 2010;7:802–810. PubMed

Salata C, Ferreira-Machado SC, De Andrade CBV, Mencalha AL, Mandarim-De-Lacerda CA, de Almeida CE. Apoptosis induction of cardiomyocytes and subsequent fibrosis after irradiation and neoadjuvant chemotherapy. Int J Radiat Biol. 2014;90:284–290. PubMed

Refaat MM, Ballout JA, Zakka P, Hotait M, Al Feghali KA, Abu Gheida I, et al. Swine Atrioventricular Node Ablation Using Stereotactic Radiosurgery: Methods and In Vivo Feasibility Investigation for Catheter-Free Ablation of Cardiac Arrhythmias. J Am Heart Assoc. 2017;6:1–7. PubMed PMC

Krug D, Blanck O, Demming T, Dottermusch M, Koch K, Hirt M, et al. Stereotactic body radiotherapy for ventricular tachycardia (cardiac radiosurgery) First-in-patient treatment in Germany. Strahlenther Onkol. 2020;196:23–30. PubMed

da Silva EZ, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. J Histochem Cytochem. 2014;62:698–738. PubMed PMC

Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunol Res. 2006;34:97–115. PubMed PMC

Aupperle H, Doll N, Walther T, Ullmann C, Schoon HA, Wilhelm Mohr F. Histological findings induced by different energy sources in experimental atrial ablation in sheep. Interact Cardiovasc Thorac Surg. 2005;4:450–455. PubMed

Stoffregen WC, Rousselle SD, Rippy MK. Pathology Approaches to Determine Safety and Efficacy of Cardiac Ablation Catheters. Toxicol Pathol. 2019;47:311–328. PubMed

Peichl P, Sramko M, Cvek J, Kautzner J. A case report of successful elimination of recurrent ventricular tachycardia by repeated stereotactic radiotherapy: the importance of accurate target volume delineation. Eur Heart J Case Rep. 2021;5:ytaa516. PubMed PMC

Haskova J, Peichl P, Sramko M, Cvek J, Knybel L, Jiravsky O, et al. Case Report: Repeated Stereotactic Radiotherapy of Recurrent Ventricular Tachycardia: Reasons, Feasibility, and Safety. Front Cardiovasc Med. 2022;9 PubMed PMC

Blanck O, Bode F, Gebhard M, Hunold P, Brandt S, Bruder R, et al. Dose-escalation study for cardiac radiosurgery in a porcine model. Int J Radiat Oncol Biol Phys. 2014;89:590–598. PubMed

Zhang DM, Navara R, Yin TK, Szymanski J, Goldsztejn U, Kenkel C, et al. Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis. Nat Commun. 2021;12(1):1–14. PubMed PMC

Cha MJ, Seo JW, Kim HJ, Kim MK, Yoon HS, Jo SW, et al. Early Changes in Rat Heart After High-Dose Irradiation: Implications for Antiarrhythmic Effects of Cardiac Radioablation. J Am Heart Assoc. 2021;10 PubMed PMC